Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 84 clinical trials
Featured trial
PET MRI as a Staging Tool for Head and Neck Cancer

To explore the use of PET/MRI in the staging and pretreatment evaluation of patients with head and neck cancer and to compare this modality to standard PET/CT imaging.

Online studies
  • 0 views
  • 29 Nov, 2021
  • 1 location
  • Online study
Featured trial
Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy (PERIOP-04)  

In preclinical models the causal link between this immune suppression and the formation of postoperative metastases is undeniable. Fortunately, this postoperative immune suppression is preventable using modulators of MDSC and NK cell function.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Featured trial
Immune Score Based Radiomics in Nasopharyngeal Carcinoma

In nasopharyngeal carcinoma (NPC), tumor, node and metastasis (TNM) staging system is the main tool for determining treatment strategy and assessment of prognosis. However, the prognoses of patients with the same TNM stage after similar treatment vary widely.

  • 0 views
  • 19 Nov, 2021
  • 5 locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

advanced breast cancer
endocrine therapy
stage iv breast cancer
adjuvant
adenocarcinoma
  • 0 views
  • 04 Dec, 2020
  • 126 locations
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

small cell lung cancer
cancer
docetaxel
squamous non-small cell lung cancer
platinum-based chemotherapy
  • 0 views
  • 04 Dec, 2020
  • 169 locations
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients  

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

small cell lung cancer
cancer
docetaxel
squamous non-small cell lung cancer
platinum-based chemotherapy
  • 0 views
  • 21 Dec, 2020
  • 52 locations
Identification and Preservation of Arm Lymphatics

Arm lymphedema, local recurrence, regional recurrence, and distant metastasis were recorded at different follow-up examinations.

  • 0 views
  • 05 Aug, 2020
Metastasis-directed Therapy in Castration-refractory Prostate Cancer

The aim is to define the postponement of next line systemic treatment (NEST), by the use of metastasis-directed therapy in patients with oligoprogressive castration-refractory prostate cancer. This will be defined by the NEST-free survival.

pet/ct
primary tumor
adenocarcinoma
docetaxel
metastasectomy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT

The results will be compared across the 2 arms. Patients with brain metastases are living longer. Maintaining functional independence and brain metastases control is thus increasingly important. Improved radiotherapy treatment techniques could provide better control and survival outcomes whilst maintain QoL and functional capacity.

neoplasm
cavities
metastasis
dental caries
edema
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

This double blind, randomized phase II trial will investigate whether the addition of tocotrienol will improve the effect and lower the toxicity of standard chemotherapy and bevacizumab. Half of the patients will receive tocotrienol and the other half placebo. Treatment is planned for a period of maximum six months and …

investigational treatment
colorectal cancer
tocotrienol
adenocarcinoma of colon
metastasis
  • 0 views
  • 16 Feb, 2024
  • 1 location